Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Dornier's BPH device approved by FDA

June 9, 1998

LU-302872, an orally active ETA/ETB antagonist for the treatment of BPH

June 5, 1998

Synthelabo discloses new agents for urinary incontinence

June 5, 1998

Ditropan XL effectively controls urge incontinence in phase III trial

June 5, 1998

Celsion to evaluate BPH system in phase I trial

June 3, 1998

RU-58642: potent new antiandrogen for androgen-dependent prostate disorders

June 2, 1998

PPD and Lilly join forces to develop genitourinary compounds

May 28, 1998

ETA antagonist has protective effects in hypertensive rat model of renal damage

May 27, 1998

Renal effects of BG-9719 demonstrated in CHF patients and healthy volunteers

May 22, 1998

Profile of eplerenone, a novel aldosterone antagonist from Searle

May 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...